Latest Posts



Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More


Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Pharmatec Series

Event Date: September 20-21, 2018
Venue: ILEC Conference Centre, London, UK

Innoplexus at Pharmatec Series

Steve Mason

Steve Mason
Vice President – Global Accounts

The annual PharmaTec Series features 3 outstanding programmes: our long-running Pharma IT Congress and fast-emerging Artificial Intelligence in Drug Development and Digital Health & Digital Technologies Congresses.

There is a global push towards novel technologies and IT systems in the pharmaceutical industry, driven by the need to improve the drug discovery process. The PharmaTec Series provides a focused networking platform geared towards exposure and discussion of these latest developments & technologies, with over 300 attendees from the global pharmaceutical organisations, top biotech companies and internationally renowned academic institutions, alongside 20+ leading solution providers such as BIOVIA, IBM Watson, ChemAxon and Tessella.

Pharmaceutical IT Summit: From leveraging big data led strategies, integrating real-world data and IoT to updates in NGS informatics and translational informatics, attendees will benefit from critical case studies and practical insights from leading figures in the field.

Artificial Intelligence in Drug Development Congress: Companies at the forefront of this field, including Insilico Medicine and BERG Health, will showcase case studies on machine learning to personalise patient treatment, AI in high-throughput screening and computer-aided drug design.

Digital Health and Digital Technologies Congress: The digital revolution is here. Focusing on digital health and digital therapeutics, key topics to be discussed include, regulatory compliance, digital health and patient engagement as well as wearable technologies, biosensors and real-time technology in clinical trials.